title: [New vaccine against trachoma].
abstract: The new vaccine against trachoma is established upon a stimulation of MALT system by oral route. The amount of IgA produced using chlamydia trachomatis serovar C is sufficient to allow a protection against infections of the same species of chlamydiae and/or of others varieties. There is a cross immunity between different serovars and different species. The vaccine could bring a protection against trachoma, chlamydial infection of human and animals.
authors.forename: P
authors.initials: P
authors.lastname: Vérin
authors.forename: S
authors.initials: S
authors.lastname: Liotet
authors.forename: F
authors.initials: F
authors.lastname: Catalan
authors.forename: B
authors.initials: B
authors.lastname: Mortemousque
authors.forename: K C
authors.initials: KC
authors.lastname: Hasseini
mesh_terms: D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D001428:Bacterial Vaccines; D002692:Chlamydia trachomatis / Q000145:classification / Q000276:immunology*; D006168:Guinea Pigs; D006801:Humans; D007070:Immunoglobulin A / Q000096:biosynthesis; D011817:Rabbits; D012703:Serotyping; D014141:Trachoma / Q000517:prevention & control*
chemical_list: D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D007070:Immunoglobulin A